ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in GH — Guardant Health, Inc.
CIK 1164508
BOSTON, MA
Position in GH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$51,246,347
New position
Shares Held
341,574
first reported quarter
Ownership
0.255%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#70
of 594 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,756,493,842 across 20 Diagnostics & Research names. GH ranks #12 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
5,163,059 | $983,459,478 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,067,078 | $561,752,542 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
1,007,394 | $505,067,055 | |
| 4 | NTRA |
Natera, Inc.
|
1,503,706 | $408,180,993 | |
| 5 | A |
Agilent Technologies, Inc.
|
1,844,954 | $245,065,239 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,250,053 | $241,535,240 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
429,012 | $227,200,465 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
167,741 | $214,290,804 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,246,347 | 341,574 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||